Literature DB >> 7526002

Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.

E Rogers1, M Ohori, V S Kassabian, T M Wheeler, P T Scardino.   

Abstract

We reviewed our experience with salvage radical prostatectomy for locally recurrent cancer in 40 patients to assess the current complication rate and the results using prostate specific antigen (PSA) as an indicator of treatment outcome and to identify better criteria for the selection of appropriate candidates for this operation. Most recurrent cancers were detected by digital rectal examination (26 patients) or increasing serum PSA levels (10). The operation was technically challenging, with 6 rectal injuries (15%), 2 requiring temporary colostomy. Serious technical complications were more common (31%) among the 29 patients who underwent pelvic lymphadenectomy at the time of initial radiotherapy than among the 11 treated with external irradiation alone (9%). Urinary incontinence persisted in 18 of 31 evaluable patients (58%) and was successfully corrected with an artificial urinary sphincter in 9. A total of 21 patients (54%) had pathologically advanced disease (seminal vesicle invasion and/or lymph node metastases). Preoperative PSA levels but not clinical stage or biopsy grade correlated with pathological stage (p < 0.03). If the PSA was less than 10 ng./ml. only 15% of the patients had an advanced pathological stage, compared to 86% if the PSA was 10 or more. After 2 to 97 months (mean 39) 2 patients died of metastatic prostatic cancer, 5 had distant metastases and none had symptomatic local recurrence. At 5 years the actuarial nonprogression rate measured by PSA was 55 +/- 20%. The only pretreatment factor predictive of progression was the serum PSA level. If the PSA was less than 10 ng./ml. the actuarial rate of progression was significantly lower than if the PSA was greater than 10 (p < 0.05). The best results were in the subset of 18 patients with cancer confined to the prostate or immediate periprostatic tissue: 82% had no progression at 5 years. Within each of these pathological stages the results of salvage prostatectomy were similar to those for standard radical prostatectomy in patients with no prior irradiation. Although technically challenging, salvage prostatectomy provides excellent control of radio-recurrent cancer confined to the prostate or immediate periprostatic tissue and is best performed before the preoperative PSA level increases to greater than 10 to 20 ng./ml.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7526002     DOI: 10.1097/00005392-199501000-00037

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  31 in total

Review 1.  Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer.

Authors:  Bernardo Rocco; Gabriele Cozzi; Matteo Giulio Spinelli; Angelica Grasso; Daniela Varisco; Rafael F Coelho; Vipul R Patel
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

Review 2.  Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes.

Authors:  Stephen B Williams; Jim C Hu
Journal:  World J Urol       Date:  2010-11-21       Impact factor: 4.226

Review 3.  Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?

Authors:  Stefano Arcangeli; Linda Agolli; Vittorio Donato
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-10

Review 4.  Assessment and therapy for voiding dysfunction after prostatectomy.

Authors:  Rodney A Appell
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

Review 5.  Cryotherapy.

Authors:  Katsuto Shinohara
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

6.  [Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy].

Authors:  A Heidenreich; R Semrau; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

7.  Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.

Authors:  Huibo Lian; Rong Yang; Tingsheng Lin; Wei Wang; Gutian Zhang; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2016-06-14       Impact factor: 2.370

8.  Feasibility and safety of robot-assisted salvage prostatectomy for recurrent prostate cancer following radiation therapy.

Authors:  Simon P Kim; Brent K Hollenbeck; Walter R Parker; Jessica Labo; David P Wood
Journal:  J Robot Surg       Date:  2008-05-10

9.  Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non-prostate malignancies.

Authors:  Timothy A Masterson; Alexei Wedmid; Jaspreet S Sandhu; James A Eastham
Journal:  BJU Int       Date:  2009-02-23       Impact factor: 5.588

10.  [Value of cystoprostatectomy in locally advanced prostate carcinoma].

Authors:  N Zantl; J E Gschwend
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.